Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients
Paul M. Ridker, James H. Revkin, Pierre Amarenco, Robert Brunell, Madelyn Curto, Fernando Civeira, Marcus D Flather, Robert J. Glynn, Jean C. Grégoire, J. Wouter Jukema, Yuri Karpov, John J.P. Kastelein, Wolfgang Köenig, Alberto J. Lorenzatti, Pravin Manga, URSZULA S. MASIUKIEWICZ, Michael J. Miller, Arend Mosterd, Ján Murín, José Carlos Nicolau, Steven E. Nissen, Piotr P. Ponikowski, Raul Dias Santos, Pamela F. Schwartz, Handrean Soran, and 6 more
The abstract is not reproduced here because its license does not permit redistribution. Read it at the original source.
Record
- Archive ID
- doi:10.1056/nejmoa1701488
- Published
- Mar 17, 2017
- Venue
- New England Journal of Medicine
- DOI
- 10.1056/nejmoa1701488
- PubMed
- 28304242
- Categories
- Lipoproteins and Cardiovascular Health
- Provenance
- openalex